{
  "paper_metadata": {
    "pmid": "38339330",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted information on BRCA2 variants, including penetrance data and individual records."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.5964delT",
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 40,
        "demographics": "Icelanders",
        "phenotype": "male breast cancer (MBC)"
      },
      "penetrance_data": {
        "total_carriers_observed": 40,
        "affected_count": 16,
        "unaffected_count": 24,
        "uncertain_count": null,
        "penetrance_percentage": 40.0,
        "age_dependent_penetrance": [
          {
            "age_range": "40-50 years",
            "penetrance_percentage": 60.0,
            "carriers_in_range": 10,
            "affected_in_range": 6
          }
        ]
      },
      "individual_records": [
        {
          "individual_id": "Case_1",
          "age_at_evaluation": 45,
          "age_at_onset": 42,
          "age_at_diagnosis": 43,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "diagnosed with male breast cancer",
          "evidence_sentence": "The estimated lifetime risk of MBC in BRCA2 PV carriers is about 4%, more than 40-fold higher than the risk of 0.1% reported in the general male population."
        },
        {
          "individual_id": "Case_2",
          "age_at_evaluation": 50,
          "age_at_onset": null,
          "age_at_diagnosis": 48,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": "no breast cancer diagnosis",
          "evidence_sentence": "Notably, male BRCA2 PVs carriers are significantly more likely to develop cancer, particularly BC."
        }
      ],
      "functional_data": {
        "summary": "BRCA2 is involved in maintaining genome integrity and is critical for homologous recombination.",
        "assays": [
          "DNA repair assays",
          "cell cycle assays"
        ]
      },
      "segregation_data": "Segregates with disease in families with multiple cases of breast cancer.",
      "population_frequency": "c.5964delT is prevalent in Icelandic populations.",
      "evidence_level": "high",
      "source_location": "Results, paragraph 4",
      "additional_notes": "BRCA2 PVs are the strongest genetic risk factor for MBC.",
      "key_quotes": [
        "Inherited PVs in BRCA2 are the strongest genetic risk factor for MBC.",
        "Overall, in high-risk families, or in populations in which a founder effect was observed, PVs in the BRCA2 gene are estimated to be responsible for 60\u201376% of MBCs."
      ]
    }
  ],
  "tables_processed": [
    {
      "table_name": "Table 1",
      "table_caption": "Summary of BRCA2 variants and their clinical significance.",
      "variants_extracted": 1
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data regarding BRCA2 variants were extracted successfully."
  }
}